Summit Therapeutics (SMMT) Earnings Date & Reports

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

SMMT is expected to report earnings to rise 40.43% to -9 cents per share on May 08

Summit Therapeutics SMMT Stock Earnings Reports

Q1'25

Est.

$-0.10

Q4'24

Beat

by $0.01

Q3'24

Beat

by $0.02

Q2'24

Missed

by $0.03

Q1'24

Beat

by $0.01

The last earnings report on February 24 showed earnings per share of -7 cents, beating the estimate of -7 cents. With 2.83M shares outstanding, the current market capitalization sits at 15.26B.

View a ticker or compare two or three

Compare

SMMT